BioNexus Gene Lab Corp. (BGLC)
USD 0.26
(-2.99%)
USD 0.26
(-2.99%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 9.77 Million | 10.92 Million | 13.36 Million | 11.39 Million | 126.95 Thousand | 212.32 Thousand |
| Cost of Revenue | 8.44 Million | 9.66 Million | 11.16 Million | 9.67 Million | 71.06 Thousand | 183.56 Thousand |
| Gross Profit | 1.32 Million | 1.25 Million | 2.19 Million | 1.71 Million | 55.88 Thousand | 28.76 Thousand |
| Operating Expenses | 3.92 Million | 1.55 Million | 1.13 Million | 446 Thousand | 331.59 Thousand | -31.13 Thousand |
| Selling, General and Administrative Expenses | 4.4 Million | 1.72 Million | 1.2 Million | 1.33 Million | 356.64 Thousand | 241.93 Thousand |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | -486.03 Thousand | -179.28 Thousand | -66.49 Thousand | -886.94 Thousand | -25.04 Thousand | 273.06 Thousand |
| Cost and Expenses | 12.36 Million | 11.21 Million | 12.3 Million | 10.11 Million | 402.66 Thousand | 152.42 Thousand |
| Operating Income | -2.59 Million | -291.17 Thousand | 1.05 Million | 1.27 Million | -275.7 Thousand | 59.9 Thousand |
| Interest Expense | 13.92 Thousand | 12.47 Thousand | 12.97 Thousand | 11.31 Thousand | - | - |
| Income Tax Expense | 21.52 Thousand | 52.31 Thousand | 291.28 Thousand | 168.41 Thousand | -29.23 Thousand | 33.44 Thousand |
| Earnings before Tax | -2.6 Million | -303.65 Thousand | 1.04 Million | 1.26 Million | -275.7 Thousand | 59.9 Thousand |
| Net Income | -2.62 Million | -355.96 Thousand | 751.57 Thousand | 1.09 Million | -246.46 Thousand | 26.45 Thousand |
| Earnings Per Share Basic | -0.17 | -0.02 | 0.05 | 0.13 | -0.03 | 0.00 |
| Earnings Per Share Diluted | -0.17 | -0.02 | 0.05 | 0.13 | -0.03 | 0.00 |
| Weighted Average Shares Outstanding | 15.87 Million | 14.4 Million | 14.26 Million | 8.57 Million | 7.19 Million | 5.52 Million |
| Weighted Average Shares Outstanding (Diluted) | 15.87 Million | 14.4 Million | 14.26 Million | 8.57 Million | 7.19 Million | 5.52 Million |
| Gross Margin | 0.14 | 0.12 | 0.16 | 0.15 | 0.44 | 0.14 |
| EBIT Margin | -0.25 | -0.02 | 0.09 | 0.12 | -1.75 | 0.47 |
| Profit Margin | -0.27 | -0.03 | 0.06 | 0.10 | -1.94 | 0.12 |
| EBITDA | -2.48 Million | -185.76 Thousand | 1.16 Million | 1.37 Million | -222.37 Thousand | 100.51 Thousand |
| Earnings Before Tax Margin | -0.27 | -0.03 | 0.08 | 0.11 | -2.17 | 0.28 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 1.97 Million | 2.38 Million | 9.77 Million | 2.27 Million | 2.55 Million | 2.56 Million |
| Cost of Revenue | 1.7 Million | 2.03 Million | 8.44 Million | 2 Million | 2.19 Million | 2.22 Million |
| Gross Profit | 268.51 Thousand | 344.89 Thousand | 1.32 Million | 266.55 Thousand | 354.33 Thousand | 339.71 Thousand |
| Operating Expenses | 739.45 Thousand | 625.76 Thousand | 3.92 Million | 9847.00 | 2.88 Million | 611.91 Thousand |
| Selling, General and Administrative Expenses | 739.45 Thousand | 625.76 Thousand | - | -15.9 Thousand | 3.08 Million | 807.07 Thousand |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | -730.1 Thousand | - | - | 479.97 Thousand | - | - |
| Cost and Expenses | 2.44 Million | 2.66 Million | 12.36 Million | 2.01 Million | 5.08 Million | 2.83 Million |
| Operating Income | -470.94 Thousand | -280.88 Thousand | -2.59 Million | 256.7 Thousand | -2.52 Million | -272.19 Thousand |
| Interest Expense | 4480.00 | 4661.00 | 13.92 Thousand | 4183.00 | 4259.00 | 3042.00 |
| Income Tax Expense | 55.58 Thousand | 20.06 Thousand | 21.52 Thousand | -54.89 Thousand | 76.41 Thousand | -15.99 Thousand |
| Earnings before Tax | 254.68 Thousand | -83.68 Thousand | -2.6 Million | 252.52 Thousand | -2.53 Million | -275.24 Thousand |
| Net Income | 199.1 Thousand | -103.75 Thousand | -2.62 Million | 307.41 Thousand | -2.6 Million | -259.25 Thousand |
| Earnings Per Share Basic | 0.01 | -0.01 | - | 0.02 | -0.16 | -0.02 |
| Earnings Per Share Diluted | 0.01 | -0.01 | - | 0.02 | -0.16 | -0.02 |
| Weighted Average Shares Outstanding | 17.66 Million | 17.66 Million | 15.87 Million | 17.66 Million | 16.77 Million | 14.47 Million |
| Weighted Average Shares Outstanding (Diluted) | 17.66 Million | 17.66 Million | 15.87 Million | 17.66 Million | 16.77 Million | 14.47 Million |
| Gross Margin | 0.14 | 0.14 | 0.14 | 0.12 | 0.14 | 0.13 |
| EBIT Margin | -0.22 | -0.11 | - | 0.13 | -0.98 | -0.10 |
| Profit Margin | 0.10 | -0.04 | -0.27 | 0.14 | -1.02 | -0.10 |
| EBITDA | -439.48 Thousand | -251.29 Thousand | - | 286.36 Thousand | -2.49 Million | -247.59 Thousand |
| Earnings Before Tax Margin | -0.24 | -0.12 | -0.27 | 0.11 | -0.99 | -0.11 |
WPP
ETCMY
WARN
7711
NLOP
ALMIL